FDA issues warning about some compounded versions of semaglutide for diabetes, weight loss

Semaglutide is FDA-approved as Ozempic and Rybelsus to treat type 2 diabetes and as Wegovy to treat overweight and obesity.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  HEALTH NEWS May 31, 2023 FDA issues warning about some compounded versions of semaglutide for diabetes, weight loss Semaglutide is FDA-approved as Ozempic and Rybelsus to treat type 2 diabetes and as Wegovy to treat overweight and obesity. More » TOP STORIES Sick workers tied to 40% of restaurant food poisoning outbreaks, CDC says » Breweries notice 'sober curious' trend gaining traction across the country » Jury selection to begin in trial of former deputy accused of failing to confront Parkland shooter » US military complains of 'unsafe, aggressive' move by Chinese fighter jet » MORE STORIES Police: Domestic violence leads to deadly Des Moines shooting » New park opening at former site of downtown Des Moines Younkers building » Death investigation: Iowa man says he shot someone breaking into his garage » Video: Surviving sibling gets huge ovation at Iowa high school graduation » MANAGE YOUR ACCOUNT If you'd like to receive some of our other email newsletters, you can tap or click the links below: Be among the first to receive National Breaking News or Local Breaking News as stories break. Catch up on the day's big stories with our Morning Headlines and Afternoon Digest newsletters. Receive our Daily Forecasts or get Severe Weather Alerts sent straight to your email inbox. Manage your email newsletter subscriptions » For the very latest information, download our free apps To ensure email delivery, add newsletters@e.kcci.com to your address book or safe senders list © 2023 Hearst Television Inc. 300 W 57th Street, New York NY 10019 Privacy Notice | Terms of Use | Unsubscribe